Edgewise Therapeutics
EWTX
EWTX
116 hedge funds and large institutions have $874M invested in Edgewise Therapeutics in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
115% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 20
36% more funds holding
Funds holding: 85 → 116 (+31)
18.02% more ownership
Funds ownership: 107.85% → 125.86% (+18%)
Holders
116
Holding in Top 10
3
Calls
$363K
Puts
$72K
Top Buyers
| 1 | +$22.6M | |
| 2 | +$19.9M | |
| 3 | +$13M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$10.4M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.32M |
Top Sellers
| 1 | -$4.32M | |
| 2 | -$2.33M | |
| 3 | -$1.99M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.93M |
| 5 |
Renaissance Technologies
New York
|
-$944K |